Is human T-cell lymphotropic virus type I really silent?

被引:39
|
作者
Asquith, B
Hanon, E
Taylor, GP
Bangham, CRM
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Immunol, London W2 1PG, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Div Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England
关键词
cytotoxic T lymphocyte; latent; HTLV-I; half-life; turnover;
D O I
10.1098/rstb.2000.0638
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of the cellular immune response to human T-cell lymphotropic virus type I (HTLV-I) is not fully understood. The low level of HTLV-I protein expression in peripheral blood lymphocytes has led to the widely held belief that HTLV-I is transcriptionally silent in vivo. However, most HTLV-I-infected individuals mount a strong and persistently activated cytotoxic T-lymphocyte (CTL) response to the virus; this observation implies that there is abundant chronic transcription of HTLV-I genes. Here we Show that HTLV-I Tax protein expression rises quickly in freshly isolated peripheral blood lymphocytes, but that expressing cells are rapidly killed by CTLs. Mathematical analysis of these results indicates that the CTL response is extremely efficient and that the half-life of a Tax-expressing cell is less than a day We propose that HTLV-I protein expression in circulating lymphocytes is undetectable by current techniques because of the efficiency of the CTL-mediated immune surveillance in vivo.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 50 条
  • [21] Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
    Hrdy, DB
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1356 - 1356
  • [22] Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
    Casseb, J
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) : 1309 - 1310
  • [23] FREQUENT DETECTION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I IN CUTANEOUS T-CELL LYMPHOMA PATIENTS
    DAVE, HPG
    JOSHI, JB
    RODRIGUEZ, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02): : 94 - 94
  • [24] Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)
    Edlich, RF
    Arnette, JA
    Williams, FM
    JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (01): : 109 - 119
  • [25] Infection of human T-lymphotropic virus type I in patients with cutaneous T-cell lymphoma
    Gao, Hong-Yang
    Shan, Yi-Fei
    Wang, Ping
    Qiu, Bing-Sen
    Wang, Song-Mei
    Fudan University Journal of Medical Sciences, 2002, 29 (01): : 36 - 38
  • [26] Human T-cell lymphotropic virus-I in Latin America
    Gotuzzo, E
    Arango, C
    de Queiroz-Campos, A
    Istúriz, RE
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (01) : 211 - +
  • [27] DETERMINATION OF A UNIQUE AND IMMUNODOMINANT EPITOPE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I
    LIPKA, JJ
    BUI, K
    REYES, GR
    MOECKLI, R
    WIKTOR, SZ
    BLATTNER, WA
    MURPHY, EL
    SHAW, GM
    HANSON, CV
    SNINSKY, JJ
    FOUNG, SKH
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02): : 353 - 357
  • [28] Human T-Cell Lymphotropic Virus Type -I: Prevalence and Incidence of Infection, a Systematic Review
    Hlela, C.
    Taylor, G.
    Shepperd, S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (11) : 1261 - 1261
  • [29] Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
    Mashkani, Baratali
    Nik, Mohammad Jalili
    Rezaee, Seyed Abdolrahim
    Boostani, Reza
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (12) : 1233 - 1248
  • [30] Chronic sensory neuronopathy associated with human T-cell lymphotropic virus type I infection
    Shimazaki, R
    Ueyama, H
    Mori, T
    Mori, M
    Fujimoto, S
    Kumamoto, T
    Tsuda, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 194 (01) : 55 - 58